COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

January 24, 2017 00:45:17
Episode Cover

Top Articles of 2016

It’s time for our annual literature update of the best and most discussed articles from 2016!  Simply a great discussion on important topics such...

Listen

Episode 0

June 17, 2022 00:37:25
Episode Cover

Life-Threatening Asthma

Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.  Of these, up to 50,000 may require...

Listen

Episode 0

August 12, 2018 00:28:22
Episode Cover

Updates in Acute Ischemic Stroke

Neurocritical Care guru Dr. Evie Marcolini is back to review recent literature and practice changes in the management of patients with acute ischemic stroke. ...

Listen